Habib NA - Search Results

1

Treatment of Liver Cancer by C/EBPA saRNA.

Zhao X, Voutila J, Ghobrial S, Habib NA, Reebye V. Zhao X, et al. Among authors: habib na. Adv Exp Med Biol. 2017;983:189-194. doi: 10.1007/978-981-10-4310-9_13. Adv Exp Med Biol. 2017. PMID: 28639200

2

p53 and gene therapy for hepatocellular carcinoma.

Habib NA, Mitry RR, Sadri R. Habib NA, et al. Adv Exp Med Biol. 1998;451:499-504. doi: 10.1007/978-1-4615-5357-1_77. Adv Exp Med Biol. 1998. PMID: 10026918 Clinical Trial. No abstract available.

3

Gene therapy for liver tumours.

Mitry RR, Mansour MR, Havlík R, Habib NA. Mitry RR, et al. Among authors: habib na. Adv Exp Med Biol. 2000;465:193-205. doi: 10.1007/0-306-46817-4_18. Adv Exp Med Biol. 2000. PMID: 10810627 Review. No abstract available.

4

Radio frequency assisted liver resection: the Habib's technique.

Jiao LR, Navarra G, Weber JC, Havlic R, Nicholls JP, Habib NA. Jiao LR, et al. Among authors: habib na. Adv Exp Med Biol. 2006;574:31-7. doi: 10.1007/0-387-29512-7_5. Adv Exp Med Biol. 2006. PMID: 16836238 No abstract available.

5

Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancer.

Reebye V, Bevan CL, Nohadani M, Hajitou A, Habib NA, Mintz PJ. Reebye V, et al. Among authors: habib na. Cell Signal. 2010 Dec;22(12):1874-81. doi: 10.1016/j.cellsig.2010.07.015. Epub 2010 Aug 2. Cell Signal. 2010. PMID: 20688158

6

Intracellular adaptor molecules and AR signalling in the tumour microenvironment.

Reebye V, Frilling A, Habib NA, Mintz PJ. Reebye V, et al. Among authors: habib na. Cell Signal. 2011 Jun;23(6):1017-21. doi: 10.1016/j.cellsig.2010.11.019. Epub 2010 Dec 3. Cell Signal. 2011. PMID: 21130868 Review.

7

A perspective on non-catalytic Src homology (SH) adaptor signalling proteins.

Reebye V, Frilling A, Hajitou A, Nicholls JP, Habib NA, Mintz PJ. Reebye V, et al. Among authors: habib na. Cell Signal. 2012 Feb;24(2):388-392. doi: 10.1016/j.cellsig.2011.10.003. Epub 2011 Oct 14. Cell Signal. 2012. PMID: 22024281 Review.

8

Cellular replacement and regenerative medicine therapies in ischemic stroke.

Thwaites JW, Reebye V, Mintz P, Levicar N, Habib N. Thwaites JW, et al. Regen Med. 2012 May;7(3):387-95. doi: 10.2217/rme.12.2. Regen Med. 2012. PMID: 22594330 Review.

9

MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral Blood.

Mintz PJ, Sætrom P, Reebye V, Lundbæk MB, Lao K, Rossi JJ, Gaensler KM, Kasahara N, Nicholls JP, Jensen S, Haoudi A, Emara MM, Gordon MY, Habib NA. Mintz PJ, et al. Among authors: habib na. Mol Ther Nucleic Acids. 2012 Aug 7;1(8):e34. doi: 10.1038/mtna.2012.29. Mol Ther Nucleic Acids. 2012. PMID: 23344176 Free PMC article.

10

Gene Expression Profile Changes After Short-activating RNA-mediated Induction of Endogenous Pluripotency Factors in Human Mesenchymal Stem Cells.

Voutila J, Sætrom P, Mintz P, Sun G, Alluin J, Rossi JJ, Habib NA, Kasahara N. Voutila J, et al. Among authors: habib na. Mol Ther Nucleic Acids. 2012 Aug 7;1(8):e35. doi: 10.1038/mtna.2012.20. Mol Ther Nucleic Acids. 2012. PMID: 23344177 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

389 results

Search Page